286 related articles for article (PubMed ID: 25288491)
21. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
Chang BH; Stork L; Fan G
Pediatr Dev Pathol; 2008; 11(1):50-4. PubMed ID: 18237230
[TBL] [Abstract][Full Text] [Related]
22. The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage.
Zeng L; Huang W; Cao Z; Zheng B; Liu X; Guo L; Feng X
Ann Hematol; 2019 Jun; 98(6):1467-1476. PubMed ID: 30895352
[TBL] [Abstract][Full Text] [Related]
23. p63 and p53 expression in extranodal NK/T cell lymphoma, nasal type.
Ye Z; Cao Q; Niu G; Liang Y; Liu Y; Jiang L; Yu X; Han A
J Clin Pathol; 2013 Aug; 66(8):676-80. PubMed ID: 23626008
[TBL] [Abstract][Full Text] [Related]
24. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.
Younes A; Bartlett NL; Leonard JP; Kennedy DA; Lynch CM; Sievers EL; Forero-Torres A
N Engl J Med; 2010 Nov; 363(19):1812-21. PubMed ID: 21047225
[TBL] [Abstract][Full Text] [Related]
25. A retrospective study on the clinicopathological and molecular features of 22 cases of natural killer/T-cell lymphoma in children and adolescents.
Wang GN; Zhao WG; Zhang XD; Jian XY; Zhang CL; Zhang MZ; Li WC
Sci Rep; 2022 May; 12(1):7118. PubMed ID: 35504960
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors and treatment outcomes for patients with stage II extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract.
Fang H; Jin J; Wang WH; Wang SL; Zhou LQ; Li YX
Leuk Lymphoma; 2014 Aug; 55(8):1832-7. PubMed ID: 24144309
[TBL] [Abstract][Full Text] [Related]
27. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
[TBL] [Abstract][Full Text] [Related]
29. Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.
Kim SJ; Kim BS; Choi CW; Choi J; Kim I; Lee YH; Kim JS
Ann Oncol; 2007 Aug; 18(8):1382-7. PubMed ID: 17693651
[TBL] [Abstract][Full Text] [Related]
30. The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.
Gravanis I; Tzogani K; van Hennik P; de Graeff P; Schmitt P; Mueller-Berghaus J; Salmonson T; Gisselbrecht C; Laane E; Bergmann L; Pignatti F
Oncologist; 2016 Jan; 21(1):102-9. PubMed ID: 26621039
[TBL] [Abstract][Full Text] [Related]
31. The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications.
Kim SH; Yang WI; Min YH; Ko YH; Yoon SO
Tumour Biol; 2016 Feb; 37(2):2037-47. PubMed ID: 26337274
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
[TBL] [Abstract][Full Text] [Related]
33. Consolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphoma.
Nie M; Bi XW; Zhang WW; Sun P; Xia Y; Liu PP; Huang HQ; Jiang WQ; Li ZM
Sci Rep; 2016 Apr; 6():23996. PubMed ID: 27041507
[TBL] [Abstract][Full Text] [Related]
34. Immunophenotypic characteristics and clinical relevance of CD56+ and CD56- extranodal nasal-type natural killer/T-cell lymphoma.
Li YX; Wang H; Feng XL; Liu QF; Wang WH; Lv N; Jin J; Wang SL; Liu YP; Fang H; Song YW; Liu XF; Zhou LQ; Wang ZY; Yu ZH
Leuk Lymphoma; 2011 Mar; 52(3):417-24. PubMed ID: 21323521
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma.
Li N; Zhang L; Song HL; Zhang J; Weng HW; Zou LQ
Tumour Biol; 2017 May; 39(5):1010428317705503. PubMed ID: 28475009
[TBL] [Abstract][Full Text] [Related]
36. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
37. IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma.
Wang L; Bi XW; Zhu YJ; He YZ; Lai QY; Xia ZJ; Cai QQ
Cancer Commun (Lond); 2018 Oct; 38(1):62. PubMed ID: 30340635
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of sonic hedgehog signaling blocks cell migration and growth but induces apoptosis via suppression of FOXQ1 in natural killer/T-cell lymphoma.
Liu P; Chen L
Leuk Res; 2018 Jan; 64():1-9. PubMed ID: 29132010
[TBL] [Abstract][Full Text] [Related]
39. A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy.
Cao J; Lan S; Shen L; Si H; Zhang N; Li H; Guo R
Oncotarget; 2017 Mar; 8(12):20362-20370. PubMed ID: 27901491
[TBL] [Abstract][Full Text] [Related]
40. Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma.
Liu X; Wu T; Zhu SY; Shi M; Su H; Wang Y; He X; Xu LM; Yuan ZY; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Wu JX; Qi SN; Yang Y; Li YX
JAMA Netw Open; 2019 Mar; 2(3):e190194. PubMed ID: 30821826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
